Bright Minds Biosciences, Inc. (DRUG)
85.67
+1.48
(+1.76%)
USD |
NASDAQ |
Dec 15, 16:00
85.40
-0.27
(-0.32%)
Pre-Market: 08:11
Bright Minds Biosciences Market Cap: 607.28M for Dec. 15, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 341.49M |
| Palatin Technologies, Inc. | 26.03M |
| Theriva Biologics, Inc. | 6.626M |
| Oragenics, Inc. | 0.6884M |
| NanoViricides, Inc. | 22.14M |
Market Cap Related Metrics
| PEG Ratio | -2.343 |
| Price to Book Value | 15.99 |
| Price | 85.67 |
| Earnings Yield | -1.11% |
| PEGY Ratio | -2.343 |